Five Prime Therapeutics buy Rathjen
Start price
23.04.17
/
50%
€30.08
Target price
07.11.17
€45.10
Performance (%)
-25.76%
End price
07.11.17
€22.33
Summary
This prediction ended on 07.11.17 with a price of €22.33. The price of Five Prime Therapeutics has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -25.76%. Rathjen has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Five Prime Therapeutics | - | - | - | - |
| iShares Core DAX® | -3.986% | -2.814% | 4.157% | 51.377% |
| iShares Nasdaq 100 | 0.345% | -0.748% | 9.471% | 85.925% |
| iShares Nikkei 225® | -3.853% | 4.229% | 28.358% | 56.859% |
| iShares S&P 500 | 0.298% | 0.379% | 6.139% | 59.567% |
Comments by Rathjen for this prediction
In the thread Five Prime Therapeutics diskutieren
Gute Einstiegschance
Hier könnte charttechnisch ein Boden gefunden werden.
Stopp bei 25,- $
s. a.
https://www.godmode-trader.de/analyse/bb-biotech-q1-zahlen-depot-umschichtungen-die-charttechnik,5269984
(Stop Loss Kurs erreicht)